Study: Regular alcohol use may reduce cancer immunotherapy effectiveness
A study published in Science Signaling found that regular alcohol consumption may weaken a common type of cancer treatment, according to Medical Xpress. Researchers used mouse models and human patient data to examine how drinking affects immune checkpoint inhibitors (ICIs), drugs that help the body's immune system attack cancer cells.
In mice with lung and bladder cancer, moderate-to-heavy alcohol consumption reduced immunotherapy success by nearly half and increased the chance tumors would return, Medical Xpress reported. Human data showed a similar pattern: lung cancer patients who drank more than one drink per week experienced fewer survival benefits after starting anti-PD-1 treatment, a type of immunotherapy.
The immune system uses white blood cells called T cells to find and destroy cancer cells. Cancer cells can block these T cells from working by activating a natural off-switch called PD-1. Anti-PD-1 drugs work by blocking this off-switch so T cells can attack tumors. According to Medical Xpress, the study found that alcohol reduced the number of tumor-fighting T cells and weakened their cancer-killing ability.
This research is early-stage and was conducted in mice and through analysis of existing patient data. The findings suggest a potential link between alcohol consumption and immunotherapy effectiveness, though more research is needed to understand the relationship in humans.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
